These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16331260)
21. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387 [TBL] [Abstract][Full Text] [Related]
22. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia. Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793 [TBL] [Abstract][Full Text] [Related]
23. Cell cycle-dependent transcription of cyclin B2 is influenced by DNA methylation but is independent of methylation in the CDE and CHR elements. Tschöp K; Engeland K FEBS J; 2007 Oct; 274(20):5235-49. PubMed ID: 17868378 [TBL] [Abstract][Full Text] [Related]
24. Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. Shim JS; Kim DH; Kwon HJ Oncogene; 2004 Mar; 23(9):1704-11. PubMed ID: 14661058 [TBL] [Abstract][Full Text] [Related]
26. DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. Geiman TM; Sankpal UT; Robertson AK; Zhao Y; Zhao Y; Robertson KD Biochem Biophys Res Commun; 2004 May; 318(2):544-55. PubMed ID: 15120635 [TBL] [Abstract][Full Text] [Related]
27. PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells. Yashiro T; Kubo M; Ogawa H; Okumura K; Nishiyama C PLoS One; 2015; 10(9):e0137699. PubMed ID: 26361334 [TBL] [Abstract][Full Text] [Related]
28. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines]. Chen YX; Fang JY; Lu J; Qiu DK Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516 [TBL] [Abstract][Full Text] [Related]
29. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins. Majumder S; Kutay H; Datta J; Summers D; Jacob ST; Ghoshal K J Cell Biochem; 2006 Apr; 97(6):1300-16. PubMed ID: 16329111 [TBL] [Abstract][Full Text] [Related]
30. Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. Zheng DL; Zhang L; Cheng N; Xu X; Deng Q; Teng XM; Wang KS; Zhang X; Huang J; Han ZG J Hepatol; 2009 Feb; 50(2):377-87. PubMed ID: 19070387 [TBL] [Abstract][Full Text] [Related]
31. Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression. Claus R; Fliegauf M; Stock M; Duque JA; Kolanczyk M; Lübbert M J Leukoc Biol; 2006 Dec; 80(6):1462-72. PubMed ID: 17000900 [TBL] [Abstract][Full Text] [Related]
32. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation. Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219 [TBL] [Abstract][Full Text] [Related]
33. Loss of PU.1 expression following inhibition of histone deacetylases. Laribee RN; Klemsz MJ J Immunol; 2001 Nov; 167(9):5160-6. PubMed ID: 11673528 [TBL] [Abstract][Full Text] [Related]
35. Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth. Tatetsu H; Ueno S; Hata H; Yamada Y; Takeya M; Mitsuya H; Tenen DG; Okuno Y Cancer Res; 2007 Jun; 67(11):5328-36. PubMed ID: 17545613 [TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. Xiong Y; Dowdy SC; Podratz KC; Jin F; Attewell JR; Eberhardt NL; Jiang SW Cancer Res; 2005 Apr; 65(7):2684-9. PubMed ID: 15805266 [TBL] [Abstract][Full Text] [Related]
37. Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes. Jiang Y; Jiang J; Xiong J; Cao J; Li N; Li G; Wang S J Exp Biol; 2008 Mar; 211(Pt 6):911-20. PubMed ID: 18310117 [TBL] [Abstract][Full Text] [Related]
38. Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cells. Endo S; Amano M; Nishimura N; Ueno N; Ueno S; Yuki H; Fujiwara S; Wada N; Hirata S; Hata H; Mitsuya H; Okuno Y Biochem Biophys Res Commun; 2016 Jan; 469(2):236-42. PubMed ID: 26657848 [TBL] [Abstract][Full Text] [Related]
39. Promoter methylation and histone modifications affect the expression of the exogenous DsRed gene in transgenic goats. Nuo MT; Yuan JL; Yang WL; Gao XY; He N; Liang H; Cang M; Liu DJ Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706651 [TBL] [Abstract][Full Text] [Related]
40. Multiple PU.1 sites cooperate in the regulation of p40(phox) transcription during granulocytic differentiation of myeloid cells. Li SL; Valente AJ; Qiang M; Schlegel W; Gamez M; Clark RA Blood; 2002 Jun; 99(12):4578-87. PubMed ID: 12036891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]